Noel Fajardo, MD
Gastroenterology · Las Vegas, NVNPI 1255305520
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $16,351 of the $21,752 with a category attached, or 75.2%. Gilead accounts for 79.3% of it on its own, with 31 other manufacturers making up the rest. Reporting peaked in 2019 at $13,089 and has fallen 94.7% since, to $694 in 2025. Among gastroenterology clinicians in NV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 212 payments — averaging $102.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$17K
- Fujifilm Healthcare Americas Corporation$679
- AbbVie$575
- Johnson & Johnson$451
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$410
- Sanofi$338
- plus $2K from 26 others
What the payments were for
- Speaking & faculty fees$16,35175%
- Travel & lodging$2621%
- Food & beverage$4,44420%
- Education$160%
- Other$6793%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 21 | $17,259 |
| Fujifilm Healthcare Americas Corporation | 2 | $679 |
| AbbVie | 26 | $575 |
| Johnson & Johnson | 23 | $451 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 26 | $410 |
| Sanofi | 15 | $338 |
| Ironwood Pharmaceuticals, Inc | 15 | $251 |
| Braintree Laboratories, Inc. | 11 | $171 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $158 |
| Nestle Healthcare Nutrition Inc. | 9 | $147 |
| QOL Medical, LLC | 7 | $116 |
| Phathom Pharmaceuticals, Inc. | 5 | $114 |
| Lucid Diagnostics Inc. | 3 | $109 |
| Mauna Kea Technologies, Inc. | 1 | $106 |
| Ferring Pharmaceuticals Inc. | 6 | $102 |
| Merck | 6 | $102 |
| Anx Robotica Corp | 1 | $100 |
| Lilly USA, LLC | 3 | $92 |
| Redhill Biopharma Inc. | 3 | $60 |
| Intercept Pharmaceuticals, Inc. | 3 | $55 |
| Bristol Myers Squibb | 3 | $54 |
| Capsovision, Inc. | 3 | $47 |
| Regeneron Healthcare Solutions, Inc. | 2 | $46 |
| Pfizer | 2 | $35 |
| Intra-sana Laboratories | 1 | $34 |
| Olympus America Inc. | 2 | $33 |
| Celltrion USA Inc. | 1 | $26 |
| Ardelyx, Inc. | 1 | $17 |
| Boston Scientific | 1 | $17 |
| Novo Nordisk | 1 | $16 |
| Daiichi Sankyo Inc. | 1 | $16 |
| Alnylam Pharmaceuticals Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$21,752 in reported general payments places this provider in the 90th percentile of 103 gastroenterology providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gastroenterology in Las Vegas
- Christian StoneLas Vegas$1.1M
- James HanLas Vegas$47K
- Filippo CremoniniLas Vegas$36K
- Vijay JayaramanLas Vegas$28K
- Gary ChenLas Vegas$27K
- David ShihLas Vegas$26K
- Frank FarisLas Vegas$14K
- Tarek AmmarLas Vegas$14K
- Eladio CarreraLas Vegas$13K
- Uday SaraiyaLas Vegas$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.